CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.
Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...
Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In recent ...
Lymphatic malformations (LMs) are congenital vascular anomalies characterized by abnormal lymphatic development, leading to ...
In hepatitis B virus (HBV) infection, the capacity to mount a functional virus-specific T-cell response has long been considered the principal, if not the sole, immunological determinant of viral ...
Autolus will evaluate Cellares’ fully automated, high-throughput manufacturing platform in preparation for expansion into new indicationsSOUTH SAN FRANCISCO, Calif. and LONDON, Jan. 06, 2026 (GLOBE ...
During a live event, Matthew Lunning, DO, interpreted long-term outcomes of the ZUMA-7 and TRANSFORM trials.
H 2026 Catalyst Stack Anticipated to Validate Scalable, Off-the-Shelf CAR T in Oncology and Autoimmune DiseaseInterim Futility Analysis of MRD Clearance from the Pivotal Phase 2 ALPHA3 Trial with ...
Certain antibodies employ unusual tactics to keep germs from attaching to cells in our bodies. Their defensive strategies ...
In an effort to extend financing support for patients seeking CAR-T cell therapy, Immuneel Therapeutics has partnered with healthcare crowdfunding platform Impact Guru, and healthcare-focussed lending ...
Verywell Health on MSN
What Happens to Your Immune System When You Take Vitamin C
It's true that vitamin C can give your immune system a boost, but when it comes to treating or preventing colds, things get a ...
Abbvie Inc. signed a $1.1 billion New Year’s Eve deal with China’s Zelgen Biopharmaceuticals Co. Ltd., gaining ex-China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback